Top Markets
#1 MowCat MowCat +49.01%
#2 Derive Derive +24.21%
#3 Audiera Audiera +19.54%
#4 Geodnet Geodnet +16.54%
#5 aPriori aPriori +15.50%
#6 Biconomy Biconomy +14.76%
#7 Cross Cross +14.26%
#8 Humanity Humanity +12.39%
#9 Quack AI Quack AI +11.55%
#10 Palladium Network Palladium Network +10.79%
Coin of the day
MowCat MowCat
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Tissue Repair Ltd Tissue Repair Ltd

Tissue Repair Ltd

TRP
Rang in Aktien #35634
Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical... Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical firm dedicated to pioneering advanced solutions for wound care. The company's primary focus lies in developing treatments for persistent chronic wounds and enhancing recovery following cosmetic procedures. Its product pipeline features TR-987 and a suite of innovative dressings and matrices, including the proprietary Glucoprime technology. These are specifically engineered to address challenging conditions such as chronic wounds, burns, and other complex dermal injuries. Additionally, TR Pro+ is being developed for post-procedure care after minimally invasive aesthetic treatments. Beyond these core programs, Tissue Repair is also exploring applications in animal health, novel bandage and scaffold technologies, and various other therapeutic areas. The company was founded in 2012 and operates from its headquarters in Sydney, Australia.
Aktienkurs
$0.05994921
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$3.62M
Veränderung (1 Tag)
-1.16%
Veränderung (1 Jahr)
-66.49%
Land
AU
Handel Tissue Repair Ltd (TRP)

Kategorie

Healthcare
P/S-Verhältnis für Tissue Repair Ltd (TRP)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Tissue Repair Ltd beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Tissue Repair Ltd von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE